Project Details
Description
A PHASE 1 OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF ANG003 IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS
| Status | Active |
|---|---|
| Effective start/end date | 8/1/23 → 8/1/25 |
Funding
- ANAGRAM THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.